https://www.selleckchem.com/products/dj4.html
We further validated the algorithm on additional datasets including unreported variants validated either through expert consensus (ENIGMA) or laboratory-based functional techniques (on BRCA1/2 and SCN5A). On all datasets, RENOVO outperformed existing automated interpretation tools. On the basis of the above validation metrics, we assigned a defined PLS to all existing ClinVar VUSs, proposing a reclassification for 67% with 90% estimated precision. RENOVO provides a validated tool to reduce the fraction of uninterpreted or misinterpreted
Like
Comment
Share
